Eulerpool Terminal
The edge that pays for itself.
Current GC Biopharma forecasts and price targets in August 2026
Ø Analyst Price Targets
208,386.00 KRW
+84.90 %
Median
209,100.00 KRW
+85.54 %
Max
231,000.00 KRW
Min
191,900.00 KRW
Last Price
112,700.00 KRW
Buy
15
Hold
1
Sell
0
The average target price for GC Biopharma is 208,386.00 KRW. (+84.90 % above the current price)
The median price target of GC Biopharma is 209,100.00 KRW.
Stock analysts from many renowned investment banks are closely examining the GC Biopharma stock. They conclude their professional GC Biopharma stock analyses with a clear recommendation for the GC Biopharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 15 | 1 | 0 | 208,386.00 KRW |
| 2026-01-01 | 14 | 1 | 0 | 194,106.00 KRW |
| 2025-12-01 | 14 | 1 | 0 | 192,780.00 KRW |
| 2025-12-01 | 14 | 1 | 0 | 192,780.00 KRW |
| 2025-11-01 | 14 | 1 | 0 | 192,780.00 KRW |
| 2025-11-01 | 14 | 1 | 0 | 191,760.00 KRW |
GC Biopharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for GC Biopharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 1.99 T KRW | 26.16 B KRW | 2,291.64 KRW |
| 2027e | 2.12 T KRW | 59.31 B KRW | 5,196.79 KRW |
| 2028e | 2.29 T KRW | 92.15 B KRW | 8,073.63 KRW |